Key result
Antithrombotic therapy reduces recurrent myocardial infarction and cardiovascular death in coronary artery disease, though benefits must be balanced against bleeding risks and drug resistance.
A review highlighting the importance of understanding the clinical pharmacology of antithrombotic drugs to balance efficacy and bleeding risks in coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Emphasizes balancing ischemic benefit against bleeding with antithrombotics in CAD; leaves open optimal individualized strategies for prospective trials.
Joachim Fauler (2009) conducted a review in Coronary heart disease. Antithrombotic drugs was evaluated. Antithrombotic therapy reduces recurrent myocardial infarction and cardiovascular death in coronary artery disease, though benefits must be balanced against bleeding risks and drug resistance.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: